The move comes after the country last month stopped using AstraZeneca’s vaccine for the same reasons.
The vaccines, made by Pfizer-BioNTech and Moderna, represent the bulk of the jabs given to the country’s population, with more than 1.2 million residents already vaccinated.
The Danish Health Authority said in a statement that it “has concluded that the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect.”
Watch: How do people feel about the AstraZeneca vaccine?
It added that the European Medicines Agency has concluded that “there is a possible link between rare but severe cases of blood clots (VITT) and the Covid-19 vaccine from Johnson & Johnson.”
“As the Covid-19 epidemic in Denmark is currently under control, and the vaccination rollout is progressing satisfactorily with other available vaccines, the Danish Health Authority has decided to continue the national vaccination campaign without the Covid-19 vaccine from Johnson & Johnson,” it continued.
Denmark, which has so far vaccinated 11.5 per cent of its population, has seen a slowing down in infection rates and has gradually started reopening hospitality venues including indoor service at restaurants and cafes.
But Helene Probst, deputy director general at the Danish Health Authority, noted Monday’s decision means that Denmark’s vaccination calendar will be pushed back up to four weeks.
The decision was made at a meeting in parliament between Health Minister Magnus Heunicke and lawmakers from the different parties.
Watch: When can I go on holiday?